We have demonstrated that comparing high and low densities of CD3+, CD4+, or CD8+ TILs alone in patients with NSCLC indicated that high densities of these subtypes of TILs alone could be a relatively pronounced predictive marker, with better associated outcomes than low infiltrate densities in terms of overall survival. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.